Boothbay Fund Management’s SpringWorks Therapeutics SWTX Stock Holding History

Boothbay Fund Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,000	Closed	-$940K	–	2153
2025 Q2	$940K	Buy	20,000 +10,000	+100%	+$445K	0.02%	702
2025 Q1	$441K	Buy	+10,000	New	+$460K	0.01%	908
2024 Q4	–	Sell	-12,800	Closed	-$410K	–	1898
2024 Q3	$410K	Buy	+12,800	New	+$478K	0.01%	1072

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Boothbay Fund Management's SWTX Position: Q3 2025 in Review

Boothbay Fund Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 18,750 shares — an estimated $881K sold.

Boothbay Fund Management first reported a position in SWTX in Q2 2021 and held it in 5 quarters. The position peaked at $1.6M in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Boothbay Fund Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Boothbay Fund Management sold 18,750 SpringWorks Therapeutics shares in Q3 2025, an estimated $881K.
Boothbay Fund Management first reported a position in SpringWorks Therapeutics in Q2 2021 and held it in 5 quarters.
Boothbay Fund Management's SpringWorks Therapeutics position peaked at $1.6M in Q1 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Boothbay Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.